15 July, 2017
(NASDAQ:WBA) traded at an unexpectedly high level on 07/13/2017 when the stock experienced a 0.63% gain to a closing price of $78.01.
A number of other research firms have also recently commented on WBA. Inc. purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $970,000. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator's stock valued at $113,000 after buying an additional 1,006 shares during the period. For the quarter, shares have been noted at 10.84%. Finally, Cipher Capital LP bought a new stake in Walgreens Boots Alliance during the fourth quarter worth approximately $4,390,000. The return on assets ratio shows how well management is employing the company's total assets to make a profit. In last 4 months performance of HK was -17.81% while its price to sale ratio is 2.03 and price to book ratio is 0.83.
Heading into the stock price potential, Walgreens Boots Alliance, Inc. needs to grow just 21.14% to cross its median price target of $94.5. WBA has diverse figures for different time frames; starting from week's performance reduced -1.42% in last five regular trading sessions. The stock was trading on below-average volume. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $88.00. The stock closing price is now trading downward to its 50 day moving average with change of -3.79%, tumbled to its 20 day moving average with figure of -0.33% and behind its 200 day moving average with value -5.67%. The company has a market capitalization of $84.44 billion, a P/E ratio of 19.93 and a beta of 1.26.
Traders are feeling more bullish on Walgreens Boots Alliance, Inc.as inferred by the downtick in short interest. Analysts have a mean recommendation of 2.40 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).
14-day Williams %R for Walgreens Boots Alliance, Inc. The Higher end of the revenue forecast is $30.66 Billion, while the Lower end of the forecast is $29.02 Billion. During the same period a year ago, the firm posted $1.18 EPS. As of the latest earnings report the EPS was $3.96 and is projected to be $5.01 for the current year with 1,070,096,000 shares now outstanding.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Share performance for the month is now at 0.82%.
On the other hand, Yamana Gold Inc.by far traveled 6.33% versus a 1-year low price of $2.21. The ex-dividend date of this dividend is Wednesday, August 16th.
WARNING: This report was first posted by Stock Observer and is the property of of Stock Observer. If you are viewing this article on another site, it was copied illegally and republished in violation of US & worldwide copyright legislation. Bangor Savings Bank's holdings in Walgreens Boots Alliance were worth $1,939,000 as of its most recent filing with the SEC.
04/04/2017 - Pivotal Research began new coverage on Walgreens Boots Alliance, Inc. giving the company a "hold" rating.
Analysts on average have given a price target of $92.24 to Walgreens Boots Alliance, Inc.
Analysts are speculating a 28.19% move, based on the high target price ($100) for the shares that is set to reach in the next 12 months. Jefferies Group LLC dropped their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a "buy" rating on the stock in a report on Wednesday, May 31st. Zacks Investment Research lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating in a research note on Wednesday, June 14th. Walgreens Boots Alliance presently has a consensus rating of Buy and an average target price of $90.47. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Walgreens Boots Alliance Company Profile Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.
